Trade Tarsus Pharmaceuticals, Inc. - TARS CFD

Add to favourite

49.92

0.16%

0.13

Low: 48.79

High: 50.22

Market Trading Hours* (UTC) Opens on Monday at 13:30

Mon - Fri: 13:30 - 20:00

Summary
Historical Data

Trading сonditions

Spread

0.13

Long position overnight fee

-0.023346%

Short position overnight fee

0.001124%

Overnight fee time

21:00 (UTC)

Min traded quantity

0.1

Currency

USD

Margin

50.00%

Stock exchange

United States of America

Commission on trade

Key Stats

Prev. Close	49.84
Open	49.04
1-Year Change	49.69%
Day's Range	48.79 - 50.22

Last Week
Last Month
Last Year
Last two Years
Max

Daily
Weekly
Monthly

Date	Close	Change	Change (%)	Open	High	Low
Apr 25, 2025	49.92	0.89	1.82%	49.03	50.22	48.56
Apr 24, 2025	49.84	2.14	4.49%	47.70	50.37	47.70
Apr 23, 2025	49.89	-0.53	-1.05%	50.42	50.72	49.20
Apr 22, 2025	49.35	1.18	2.45%	48.17	49.50	47.14
Apr 21, 2025	48.47	0.89	1.87%	47.58	49.24	47.36
Apr 17, 2025	49.02	-0.24	-0.49%	49.26	49.76	48.59
Apr 16, 2025	49.19	2.24	4.77%	46.95	49.40	46.95
Apr 15, 2025	48.98	1.00	2.08%	47.98	49.64	47.27
Apr 14, 2025	48.49	2.11	4.55%	46.38	48.65	45.92
Apr 11, 2025	46.27	3.50	8.18%	42.77	46.45	42.77
Apr 10, 2025	44.03	-0.37	-0.83%	44.40	44.77	41.65
Apr 9, 2025	45.77	2.32	5.34%	43.45	46.10	40.32
Apr 8, 2025	44.61	-3.48	-7.24%	48.09	48.32	43.41
Apr 7, 2025	47.39	3.42	7.78%	43.97	48.66	43.54
Apr 4, 2025	46.93	-0.68	-1.43%	47.61	48.54	45.74
Apr 3, 2025	49.43	-0.03	-0.06%	49.46	51.30	47.55
Apr 2, 2025	51.38	3.77	7.92%	47.61	51.75	47.61
Apr 1, 2025	48.87	-2.08	-4.08%	50.95	50.95	48.64
Mar 31, 2025	51.31	1.41	2.83%	49.90	51.48	47.45
Mar 28, 2025	51.62	3.00	6.17%	48.62	52.02	48.62

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission

Leverage

2:1

20
100
500
1000
10000

Investment

Trade size (Leverage x Investement):

Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Tarsus Pharmaceuticals, Inc. Company profile

About Tarsus Pharmaceuticals Inc

Tarsus Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapeutic candidates to address ophthalmic conditions. Its lead product candidate, TP-03, is a therapeutic being developed for the treatment of blepharitis caused by the infestation of Demodex mites (Demodex blepharitis). TP-03 is a therapeutic based on the drug, lotilaner, which is designed to paralyze and eradicate mites and other parasites through the inhibition of parasite-specific gamma-aminobutyric acid-gated chloride (GABA-Cl) channels. The Company is also developing additional clinical-stage product candidates with lotilaner. These include TP-04 for the treatment of rosacea as well as TP-05 for Lyme prophylaxis and community malaria reduction.

Financial summary

BRIEF: For the nine months ended 30 September 2021, Tarsus Pharmaceuticals Inc revenues increased from $0K to $56.7M. Net income applicable to common stockholders totaled $1M vs. loss of $15.3M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Basic Earnings per Share excluding Extraordinary Items increased from -$0.82 to $0.05.

Industry:

Pharmaceuticals (NEC)

15440 Laguna Canyon Road
IRVINE
CALIFORNIA 92618
US

News

ECB interest-rate forecasts – Projections for the next five years

The European Central Bank (ECB) plays a pivotal role in the economic stability of the eurozone, meaning ECB interest-rate forecasts are key to understanding how financial and economic scenarios might evolve.

14:37, 10 April 2025

BlackRock shareholders: Who owns the most BLK stock?

BlackRock is the leading asset manager in the world – but who are its biggest shareholders? Read on to find out.

13:46, 9 April 2025

Rendering of physical bitcoin tokens on black background

Bitcoin price predictions 2025–2050: third-party price target

We examine bitcoin price predictions for 2025 and beyond, with insights from third-party analysts and market experts.

10:28, 9 April 2025

Tesla (TSLA) stock forecast 2025 and beyond: third-party Tesla price target

Where will Tesla’s stock be in five years? Can the EV company keep its crown?

08:19, 9 April 2025

JasmyCoin price predictions 2025-2030: Third-party price target

How might JASMY behave in the future?

16:13, 8 April 2025

Signage outside the entrance of the Reserve Bank of Australia building in Sydney, Australia.

Australian interest-rate projections: where will rates be in 5 years?

As one of the most closely watched economic indicators, Australian interest-rate projections offer valuable insight into the future of the country’s economy.

21:37, 7 April 2025